GPC3 and hepatocellular carcinoma: In xenograft mouse models, CAR-T cells targeting GPC3 have been shown to eradicate GPC3-positive HCC [76], while a phase I trial of anti-GPC3 CAR-T cells with or without lymphodepletion treatment has been conducted in six patients with relapsed or refractory GPC3 positive HCC.